LACEY KOLB: Open Payments
NPI 1295119360 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 32 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $286 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $165 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
| LivaNova USA, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, AUSTEDO XR, FANAPT, INGREZZA, TRINTELLIX, HETLIOZ, Auvelity, ARISTADA.
Industry payments across OH — which companies pay providers there.
